U.S. Multiple Myeloma Market

U.S. Multiple Myeloma Market

 

RELEASE DATE
27-Mar-2007
REGION
North America
Research Code: N083-01-00-00-00
SKU: HC02000-NA-MR_07290
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02000-NA-MR_07290

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of three new drugs. The dynamics of this market are changing rapidly and the forecast through 2013 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.

Table of Contents

Executive Summary

  • Executive Summary

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Blood Cancer Overview

  • Blood Cancer Biology
  • Blood Cancer Definitions

Multiple Myeloma Overview

  • Etiology
  • Staging and Prognostic Factors
  • Treatment Overview

Patient Forecasts

  • Prevalence
  • Incidence
  • Mortality
  • Staging

General Market Trends

  • Industry Challenges and Strategies
  • Market Drivers

Approved Product Analysis

Pipeline Analysis

Introduction

Market Revenue Forecasts

Product Revenue Forecasts

Decision Support Databases

Related Research
The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of three new drugs. The dynamics of this market are changing rapidly and the forecast through 2013 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number N083-01-00-00-00
Is Prebook No